MetaTOC stay on top of your field, easily

Evaluation of hepatitis B virus screening and reactivation in patients with hematological malignancies receiving rituximab-based chemoimmunotherapy: A single-center retrospective study

, , , , , , , , , ,

Journal of Oncology Pharmacy Practice

Published online on

Abstract

Journal of Oncology Pharmacy Practice, Ahead of Print.
IntroductionHepatitis B reactivation (HBVr) is a serious problem in patients with B-cell lymphoproliferative neoplasms receiving rituximab-based chemoimmunotherapy. This retrospective study aimed to evaluate the use of hepatitis B virus (HBV) screening ...